Key result
Initial treatment with losartan/hydrochlorothiazide increased the proportion of patients achieving goal blood pressure at 4 weeks compared to losartan monotherapy.
Why the study?
Does initial treatment with losartan/hydrochlorothiazide combination therapy improve achievement of goal blood pressure compared to losartan monotherapy in patients with severe hypertension?
RCT (n=585)
Double-blind
randomized
Does initial treatment with losartan/hydrochlorothiazide combination therapy improve achievement of goal blood pressure compared to losartan monotherapy in patients with severe hypertension?
Initial combination therapy with losartan/hydrochlorothiazide is more effective and better tolerated than losartan monotherapy for achieving blood pressure goals in severe hypertension.
Answers are grounded in this paper and cite their sources.
Initial losartan/HCTZ achieved BP goals more often than monotherapy; leaves open whether this extends to CV outcomes in severe hypertension.
Patients with severe hypertension are at high risk for cardiovascular events. The authors hypothesized that initial treatment with a combination angiotensin receptor blocker/diuretic agent would be safe and more effective than initial treatment with a single agent for these patients. In this 6-week, double-blind trial, 585 patients were randomized to losartan/hydrochlorothiazide or losartan as monotherapy and titrated as needed at 2-week intervals to reach goal blood pressure (<90 mm Hg). Almost twice as many patients achieved goal at the primary end point of 4 weeks on 50 mg losartan/12.5 mg hydrochlorothiazide vs. the losartan regimen (50-100 mg; p=0.002). Additionally, almost three times as many patients achieved goal blood pressures at 6 weeks (p<0.001). Adverse experiences on losartan/hydrochlorothiazide (43%) were significantly less than with the angiotensin receptor blocker alone (52.6%). This study confirmed the efficacy and tolerability of initial use of a fixed combination of losartan/hydrochlorothiazide vs. losartan without a thiazide.
No takes yet. Share an insight, caveat, or question.
Salerno et al. (2004) conducted an RCT in severe hypertension (n=585). losartan/hydrochlorothiazide vs. losartan monotherapy (50-100 mg) was evaluated on achieved goal blood pressure (<90 mm Hg) at 4 weeks (p=0.002). Initial treatment with losartan/hydrochlorothiazide increased the proportion of patients achieving goal blood pressure at 4 weeks compared to losartan monotherapy.
Synapse has enriched 10 related papers. Consider them for comparative context: